Displaying drugs 15551 - 15575 of 15716 in total
Mebicar
Experimental
Lawsone
Experimental
BTA9881
BTA9881 is a respiratory syncytial virus (RSV) antiviral drug developed by the Australian company Biota Holdings. It is currently in phase I trials.
Investigational
Plinabulin
Investigational
Isopentyl Pyrophosphate
Experimental
Pentyl Trihydrogen Diphosphate
Experimental
1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE
Experimental
CHGN111
CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative stress. It...
Investigational
R1295
R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis.
Investigational
Flaviolin
Experimental
Rindopepimut
Rindopepimut (CDX-110) is an injectable peptide cancer vaccine which targets a mutant protein called EGFRvIII present in about 25% to 30% of glioblastoma cases. The vaccine consists of the EGFRv3-specific peptide (a 13-amino acid mutant vIII epitope) conjugated to the non-specific immunomodulator keyhole limpet hemocyanin (KLH). The US FDA granted...
Investigational
8-azaxanthine
Experimental
3,5-Diaminophthalhydrazide
Experimental
Nitrosoethane
Experimental
Methionine Phosphinate
Experimental
Tioxolone
Experimental
ICA-105665
ICA-105665 is a novel small molecule compound for the treatment of epilepsy. It is a novel opener of the KCNQ ion channel which in preclinical studies has demonstrated a broad spectrum of activity in models of epilepsy. In addition, ICA-105665 has also demonstrated activity in certain models of neuropathic pain.
Investigational
Avilamycin
Vet approved
Matched Iupac: … 'R,7aR)-6-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4S,5S,6S)-6-[(2R,3aS,3'aR,6'R,7R,7'S,7aR,7'aR)-7'-acetyl-6'-methyl …
6-Hydroxy-5-undecyl-4,7-benzothiazoledione
Experimental
MBT-0312
MediGene's newly acquired drug candidates MBT-0312 aim at a novel method of cancer therapy by "starving out" tumors.
Investigational
Napabucasin
Napabucasin has been investigated for the treatment of Colorectal Carcinoma.
Investigational
Pridopidine
Pridopidine has been used in trials studying the treatment of Huntington's Disease.
Investigational
Displaying drugs 15551 - 15575 of 15716 in total